Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma
Clinical trial NCT02322775 · COMPLETED
Trial details
- NCT number
- NCT02322775
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-02
- Primary completion
- 2015-10-07
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.